GeneDx  Corp. logo

GeneDx Corp.

WGS | NASDAQ
Chart Builder DCF Calculator
$87.70
-$10.13 (-10.35%)
Sep 22, 2026, 1:32 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-21.02M -52.29M -175.77M -548.98M -245.39M -241.34M
Depreciation & Amortization
25.22M 21.95M 35.83M 59.31M 21.81M 11.73M
Stock-Based Compensation
32.16M 9.14M -326K 41.98M 219.42M 120.23M
Other Working Capital
11.97M 3.72M -2.53M -8.46M 13.17M 33.44M
Other Non-Cash Items
12.51M 17.79M -721K 141.53M -194.35M 2.4M
Deferred Income Tax
n/a -343K -926K -49.12M n/a n/a
Change in Working Capital
-15.6M -24.75M -38.24M 36.13M 8.08M 13.85M
Operating Cash Flow
33.28M -28.5M -180.15M -319.16M -190.43M -93.13M
Capital Expenditures
-19.02M -5.49M -5.71M -14.32M -20.79M -31.97M
Cash Acquisitions
-32.86M n/a -8.11M -127M n/a n/a
Purchase of Investments
-55.68M -66.3M -47.67M n/a n/a n/a
Sales Maturities Of Investments
46.03M 41.66M 17.77M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a -11.39M -7.88M
Investing Cash Flow
-61.52M -30.13M -43.73M -141.33M -20.79M -31.97M
Debt Repayment
-3.66M -3.23M 42.95M -3.29M -13.47M 11.73M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 891K 285K 2.95M 64.51M n/a
Financial Cash Flow
48.03M 44.16M 186.24M 197.32M 493.73M 129.06M
Net Cash Flow
19.79M -14.47M -37.72M -263.17M 282.51M 3.95M
Free Cash Flow
14.26M -33.99M -185.86M -333.48M -211.22M -125.1M
Adj. Free Cash Flow
-17.9M -43.13M -185.53M -375.45M -430.64M -245.33M
Maintenance CapEx
n/a n/a -5.71M -8.57M -13.75M -31.97M
Growth CapEx
-19.02M -5.49M n/a -5.75M -7.04M n/a
Owner Earnings
33.28M -28.5M -185.86M -327.73M -204.18M -125.1M

© 2026 bestshares.com. All rights reserved.